Howard Hughes Medical Institute’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Howard Hughes Medical Institute's PFE Position: Q1 2026 in Review
Howard Hughes Medical Institute sold out of Pfizer (PFE) in Q1 2026, closing a stake of 1,226 shares — an estimated $30.5K sold.
Howard Hughes Medical Institute first reported a position in PFE in Q2 2013 and held it in 12 quarters. The position peaked at $468K in Q4 2014. 2,952 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Howard Hughes Medical Institute reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Howard Hughes Medical Institute sold 1,226 Pfizer shares in Q1 2026, an estimated $30.5K.
- Howard Hughes Medical Institute first reported a position in Pfizer in Q2 2013 and held it in 12 quarters.
- Howard Hughes Medical Institute's Pfizer position peaked at $468K in Q4 2014.
- 2,952 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.